Company intelligence / Profile preview

Therabron Therapeutics

Rockville, Maryland, United Statesdls.maryland.gov ↗

Ownership: Private
Development stage: Other

Overview

The company developed recombinant human CC10/secretoglobin-based biologic drugs for respiratory diseases. Lead product was ready to enter Phase 2 clinical trials for persistent sinusitis and use in premature infants with unmet needs in respiratory care. No recent clinical results are available due to the company's dissolution

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: ProteinRecombinant proteinBiologic
Industry: Biotech

Beyond the preview

Go deeper on Therabron Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Therabron Therapeutics.

Explore the full profile